OTC:RGBP | Cash Flow Statement | Regen BioPharma Inc

Complete source-backed cash-flow history.

Available history
2013-03-31 to 2026-06-30
Data captured

Historical Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2026-06-30-$637,785.00
2026-03-31$991,927.00
2025-12-31-$967,853.00-$197,941.00$132,964.00
2025-09-30-$572,469.00-$160,005.00$227,799.00
2025-06-30-$167,292.00
2025-03-31-$19,354.00
2024-12-31-$515,384.00-$66,379.00$65,799.00
2024-09-30-$270,748.00-$207,289.00$146,157.00
2024-06-30-$130,120.00
2024-03-31-$122,454.00
2023-12-31-$144,933.00-$162,336.00$165,797.00
2023-09-30-$325,027.00-$23,405.00$143,750.00
2023-06-30-$99,218.00
2023-03-31-$54,978.00
2022-12-31$1.64M-$10,463.00$0.00$0.00
2022-09-30-$78,026.00-$85,287.00$499.00
2022-06-30$66.96M
2022-03-31-$67.08M
2021-12-31$2.64M-$279,135.00$0.00-$94,535.00
2021-09-30-$1.38M-$1.07M$195,000.00$1.41M
2021-06-30-$7.49M
2021-03-31$442,183.00
2020-12-31$1.67M$0.00$0.00$0.00
2020-09-30$1.2M$0.00$0.00$0.00
2020-06-30$3.21M
2020-03-31-$4.08M
2019-12-31$3.08M$24,302.00$0.00-$31,800.00
2019-09-30$1.87M-$136,964.00$0.00$143,008.00
2019-06-30-$4.41M
2019-03-31-$333,177.00
2018-12-31$245,057.00-$150,032.00$49,858.00$131,250.00
2018-09-30-$981,602.00-$465,636.00$0.00$418,250.00
2018-06-30-$107,596.00
2018-03-31-$1.13M
2017-12-31-$2.79M-$627,265.00$0.00$619,000.00
2017-09-30-$1.34M-$623,017.00$491,363.00
2017-06-30-$2.62M
2017-03-31-$1.31M
2016-12-31-$2.52M-$504,295.00$700,191.00
2016-09-30-$2.45M-$398,495.00$283,000.00
2016-06-30-$2.36M
2016-03-31-$1.09M
2015-12-31-$1.86M-$425,403.00$555,300.00
2015-09-30-$600,684.00-$338,962.00$169,000.00
2015-06-30-$1.56M
2015-03-31-$8.81M
2014-12-31-$219,191.00-$197,103.00$250,725.00
2014-09-30-$194,602.00$140,969.00
2014-06-30-$166,021.00
2014-03-31-$186,201.00
2013-12-31-$209,529.00$345,000.00
2013-09-30$159,932.00
2013-06-30-$74,829.00
2013-03-31-$70,505.00

Annual Cash Flow Statement

DateNet incomeDepreciation and amortizationOperating cash flowCapital expenditureInvesting cash flowShare repurchasesDividends paidFinancing cash flow
2025-09-30-$1.27M-$383,591.00$452,430.00
2024-09-30-$668,255.00-$751,536.00$631,215.00
2023-09-30$1.16M-$173,917.00$243,750.00
2022-09-30$2.44M-$606,921.00$25,000.00-$94,036.00
2021-09-30-$6.77M-$1.13M$495,000.00$1.36M
2020-09-30$3.41M$18,645.00$0.00-$26,500.00
2019-09-30-$2.62M-$481,792.00$49,858.00$431,771.00
2018-09-30-$4.72M-$1.58M-$5,741.00$1.32M
2017-09-30-$5.84M-$1.89M$0.00$2.14M
2016-09-30-$7.75M-$1.67M$1.66M
2015-09-30-$11.2M-$1.19M$1.23M
2014-09-30-$756,353.00$630,969.00
2013-09-30-$355,034.00$399,835.00